SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Perspectives in Vascular Surgery and Endovascular Therapy
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lawrence, P. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lawrence, P. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery

Peter F. Lawrence, MD

Vascular Surgery, David Geffen School of Medicine, UCLA Gonda Vascular Center, 200 Medical Plaza, Ste 510-6, Box 956908, Los Angeles, CA 90095-6908; pflawrence{at}mednet.ucla.edu

Underlying coronary heart disease may put patients undergoing major vascular surgery at increased risk of perioperative mortality. Perioperative mortality may be reduced by statins (inhibitors of 3-hydroxy-3-methalglutaryl coenzyme A) because they improve lipid profiles and also stabilize coronary plaques on the vascular wall. The authors evaluated the association between perioperative morality and statin use by conducting a case-control study among 2816 patients at Erasmus Medical Center who had major vascular surgery between 1991 and 2000. The case subjects were the 5.8% (160 patients) who died during the hospital stay after surgery. Two controls were selected from the remaining patients for each case and were sorted according to calendar year and type of procedure. Information on statin use before surgery, use of other cardiovascular medication, and the presence of cardiac risk factors was obtained for cases and controls. The primary cause of death in 65% (104) of the case subjects was a vascular complication. The controls had significantly more statin use than the case subjects (25% versus 8%). Similar results were obtained in subgroups of patients according to the use of cardiovascular therapy and the presence of cardiac risk factors. The authors concluded that statin reduces perioperative mortality in patients who undergo major vascular surgery.

Key Words: statin • mortality • vasculature • surgery

Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 16, No. 2, 151-153 (2004)
DOI: 10.1177/153100350401600221


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement